Source: Contract Pharma

Calypso: Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing

AGC Biologics scales up production to support Calypso's clinical trials.

Read full article »
Calypso's Competitors | Calypso's News | Calypso's Financials
Stay up-to-date with the latest news on Calypso Biotech
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alain Vicari's photo - Co-Founder & CEO of Calypso Biotech

Co-Founder & CEO

Alain Vicari

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Calypso Biotech